Myeloproliferative Disorders: all 640 studies

Page 7 of 7. Open to participants first (111), then studies with results posted, then the rest; newest registration first within each.

• St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for CancerCompletedNCT00005805Phase 3
• Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005804Phase 2
• Bone Marrow Transplant in Treating Patients With Hematologic CancersCompletedNCT00005797Phase 2
• Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationTerminatedNCT00005641Phase 2
• Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersCompletedNCT00005622Phase 2
• Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004904Phase 1
• Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00004899Phase 2
• Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00004896Phase 2
• Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00004871Phase 1
• EMD 121974 in Treating Patients With Locally Advanced or Metastatic CancerCompletedNCT00004258Phase 1
• Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic LeukemiaCompletedNCT00004245Phase 1
• 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentTerminatedNCT00004239Phase 1
• Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00004232Phase 1
• Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid MetaplasiaCompletedNCT00004181Phase 2
• 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow DisorderTerminatedNCT00004058Phase 1
• Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerStatus unknownNCT00004036Phase 1
• Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic SyndromeCompletedNCT00003961Phase 2
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic DiseaseCompletedNCT00003913Phase 2
• Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
• Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
• Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaCompletedNCT00003619Phase 1/2
• Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
• Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic SyndromeCompletedNCT00003593Phase 3
• Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced CancerCompletedNCT00003451Phase 1
• Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerCompletedNCT00003408Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerCompletedNCT00003406Phase 1/2
• Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic ConditionsCompletedNCT00003336Phase 2
• Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic CancerCompletedNCT00003335Phase 2
• Combination Chemotherapy in Treating Patients With Advanced CancerCompletedNCT00003331Phase 1
• Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerCompletedNCT00003243Phase 1
• High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00003116Phase 2
• Interleukin-12 in Treating Patients With Hematologic Cancers or Solid TumorsCompletedNCT00003107Phase 1
• Monoclonal Antibody Therapy in Treating Patients With Advanced CancerCompletedNCT00003082Phase 1
• Decitabine in Treating Patients With Melanoma or Other Advanced CancerCompletedNCT00002980Phase 1
• Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic CancerCompletedNCT00002809Phase 2
• Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative DisordersCompletedNCT00002792Phase 2
• Interleukin-2 in Treating Patients With Myelodysplastic SyndromeCompletedNCT00002746Phase 1
• Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic CancerCompletedNCT00002742Phase 3
• T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic AnemiaCompletedNCT00002718Phase 2
• Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic CancerCompletedNCT00002504Phase 2

← Myeloproliferative Disorders overview